Micro-RNAs in cognition and cognitive disorders: Potential for novel biomarkers and therapeutics

Biochem Pharmacol. 2016 Mar 15:104:1-7. doi: 10.1016/j.bcp.2015.11.021. Epub 2015 Nov 25.

Abstract

Micro-RNAs (miRNAs) are small regulatory non-coding RNAs involved in the regulation of many biological functions. In the brain, they have distinct expression patterns depending on region, cell-type and developmental stage. Their expression profile is altered by neuronal activation in response to behavioral training or chemical/electrical stimulation. The dynamic changes in miRNA level regulate the expression of genes required for cognitive processes such as learning and memory. In addition, in cognitive dysfunctions such as dementias, expression levels of many miRNAs are perturbed, not only in brain areas affected by the pathology, but also in peripheral body fluids such as serum and cerebrospinal fluid. This presents an opportunity to utilize miRNAs as biomarkers for early detection and assessment of cognitive dysfunctions. Further, since miRNAs target many genes and pathways, they may represent key molecular signatures that can help understand the mechanisms of cognitive disorders and the development of potential therapeutic agents.

Keywords: Alzheimer’s disease; Biomarkers; Cognitive dysfunctions; Learning and memory; miRNA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers / blood
  • Biomarkers / cerebrospinal fluid
  • Cognition / drug effects*
  • Cognition Disorders / drug therapy
  • Cognition Disorders / genetics*
  • Humans
  • Learning / drug effects
  • MicroRNAs / blood
  • MicroRNAs / cerebrospinal fluid
  • MicroRNAs / genetics*
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / genetics
  • Oligonucleotides / administration & dosage
  • Oligonucleotides / therapeutic use*

Substances

  • Biomarkers
  • MicroRNAs
  • Oligonucleotides